Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(4):525-30
Article Links
Anaerobic Spondylodiscitis caused by Parvimonas Micra in a Rheumatoid Arthritis Patient: Case Report and Review of the Literature
Panagiotis Kalmoukos1, Dimitrios Kouroupis1, Georgios Sapouridis2, Elisavet Simoulidou1, Anna Varouktsi1, Charalampos Zarras3, Konstantinos Petidis1, Athina Pyrpasopoulou1
Authors Information

12nd Propaedeutic Department of Internal Medicine, 2Department of Radiology, 3Lab of Microbiology, Hippokration Hospital Thessaloniki, Thessaloniki, Greece

Abstract

We report the rare case of Parvimonas micra bacteraemia and secondary spondylodiscitis probably triggered by tooth injury in a rheumatoid arthritis patient. Anaerobic bacteria associated spondylodiscitis may evade diagnosis due to atypical clinical presentation usually lacking fever, and the difficulties related to microbiological characterisation of the pathogen. Even though anaerobic spinal infections may constitute <3% of the total, clinical suspicion should remain high, especially in the case of positive history for pre-existing oral cavity or gastrointestinal/gynaecological tract infections.


Cite this article as: Kalmoukos P, Kouroupis D, Sapouridis G, Simoulidou E, Varouktsi A, Zarras C, Petidis K, Pyrpasopoulou A. Anaerobic Spondylodiscitis caused by Parvimonas Micra in a Rheumatoid Arthritis Patient: Case Report and Review of the Literature. Mediterr J Rheumatol 2023;34(4):525-30

Article Submitted: 11 May 2023; Revised Form: 03 Jun 2023; Article Accepted: 18 Jun 2023; Available Online: 24 Aug 2023

This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).

https://doi.org/10.31138/mjr.240823.asc

Keywords: anaerobic, spondylodiscitis, Parvimonas micra, rheumatoid arthritis, patients
Full Text

INTRODUCTION

Pyogenic spondylodiscitis is a rare bacterial infection affecting more frequently the elderly.1 It’s pathophysiology is based on the inoculation of pathogenic bacteria either directly during spinal surgery or haematogenously, leading to the infectious  degeneration of the vertebral body and intervertebral disc.2 Patients usually suffer from chronic comorbidities, such as diabetes, renal and hepatic failure, and immunosuppression, and are, more frequently, older men.3 The incidence of spondylodiscitis appears to have increased considerably in the recent years, peaking in people aged 75 years and older.4 Clinical presentation of pyogenic spondylodiscitis typically involves back pain or radiating pain, followed by fever, neurological deficits and systemic symptomatology (weight loss, night sweats, etc).5 Laboratory parameters, such as inflammatory markers (C-reactive protein) are elevated at presentation and their course tends to correlate with response to treatment.6 Microbiological diagnosis of the responsible pathogen is central to successful treatment and is associated with better clinical outcome.7,8 To enhance diagnostic yield, besides standard microbiological cultures, fine needle aspirates or core biopsies may be applied. Among common bacterial pathogens, Staphylococcus aureus remains the most frequently identified microorganism; however, in elderly patients the incidence of gram negative bacteria – associated spondylodiscitis is increased compared to their younger counterparts.9 Anaerobic spondylodiscitis, despite rare, (accounting for less than 3% of pyogenic vertebral osteomyelitis cases) should always be taken into consideration and microbiologically pursued.10 We report here the rare case of Parvimonas micra induced pyogenic spondylodiscitis in a 68-year-old female rheumatoid arthritis patient after obtaining written informed consent.

 

CASE REPORT

A 68-year-old female patient presented to the Emergency Department complaining of aggravating back pain after a fall occurring 20 days prior to admission, rendering her bed-bound. At the fall there was reportedly tooth fracture. She additionally reported gradual loss of appetite and weight loss.

The patient’s history was positive for rheumatoid arthritis under treatment with hydroxychloroquine and occasional use of injectable steroids, arterial hypertension, and a previous ischemic stroke without residual neurological deficits. One year previously the patient had suffered a similar fall which ended in spinal osteoporotic fractures in the lower thoracic spine. At the time the patient had received antiosteoporotic treatment because of severe vitamin D insufficiency.

Upon admission the patient was normotensive, mildly tachycardic (90bpm), and afebrile. Physical examination was positive for severe pain, localized in the lower thoracic spine. The patient complained of mild radiation of the pain to the lower extremities and tenderness of the left knee, which pre-existed, and was attributed to the patient’s arthritis history. Laboratory tests upon admission revealed leucocytosis (White Blood Cells- WBC 16,500/ul – 86,6% Neutrophils-NE), and increased inflammatory markers (C-Reactive Protein [CRP] 149,8mg/L, normal values-nv <5). Chest-X-Ray and urinalysis were unremarkable. Urinary culture was negative. X-rays of the thoracic and lumbar spine showed old fractures of T12-L1. Two sets of blood cultures were taken upon admission and a third 48h later, when fever of 37.8oC was recorded. Two of the blood cultures grew Parvimonas micra. Initial antibiotic treatment (ciprofloxacin and teicoplanin) was modified to IV penicillin (16MU/d) and IV clindamycin (600mg qd) after completion of the microbiological analysis and sensitivity testing (bioMérieux Vitek 2 system according to the EUCAST sensitivity breakpoints). A magnetic resonance imaging of the lumbar spine was requested which revealed spondylodiscitis affecting T12-L2 vertebrae with abnormal enrichment in the surrounding paravertebral soft tissue and small abscess formation bilaterally within the psoas (Figure 1). A transthoracic cardiac ultrasound was performed without any evidence of endocarditis. Fine needle biopsy was not conducted due to the indicative clinical and radiological picture and the positive blood cultures in the absence of other primary foci. Subsequent blood cultures under treatment did not grow any pathogens. The patient responded rapidly clinically with concomitant normalisation of the laboratory tests and was released on oral clindamycin. Neurosurgeons consented for gradual mobilisation after release.


Figure 1. Imaging of the patient’s lumbar spine. (A) X-Ray of the lumbar spine showing compression of T12 and wedge-shaped deformity of L1 (white asterisk). (B-D) sagittal MRI lumbar spine. (B) T1-weighted MRI image of the lumbar spine and (C) fat-saturated T1-weighted MRI image (STIR) with post-contrast enhancement of the signal in the affected vertebrae and the surrounding tissues. (D) T2- weighted image (fluid signal - asterisk) differentiating the finding from metastatic lesions. (E-F) Axial MRI lumbar spine, black asterisks point to psoas abscesses. (F) Black arrow points to destruction of the vertebral body.

 

 

DISCUSSION

Successful treatment of vertebral osteomyelitis depends on a variety of factors, most importantly prompt identification of the pathogen, early diagnosis, neurological deficits at diagnosis and underlying endocarditis.11 Anaerobic spondylodiscitis may indeed evade diagnosis, due to its atypical clinical presentation rarely accompanied by fever, the specific microbiological properties of the pathogens involved, and its radiological diversities.12 As in most musculoskeletal diseases, MRI remains the method of choice to distinguish between infectious degeneration of the vertebrae and intervertebral discs and other pathologies, eg, degenerative diseases, tumours, etc. Magnetic resonance imaging allows for the detection of bone oedema, an important early finding in vertebral osteomyelitis, while the administration of intravenous contrast agents allows for the detection of soft tissue infection and formed abscesses.13

Parvimonas micra, recently renamed from Peptostreptococcus, was first identified as the causative agent of spondylodiscitis in 1986.14 To identify cases of spondylodiscitis and/ or arthritis reported in the literature, a literature search of PubMed and Scopus was performed using the keywords spondylitis, spondylodiscitis, arthritis, Parvimonas and Peptostreptococcus. A total of 31 cases were identified and summarised in Table 1.14-33 Parvimonas micra is a Gram positive, anaerobic coccus, which colonises the gastrointestinal tract and is frequently implicated in infectious complications of the oral cavity.34 The history of fall and tooth fracture may indeed have provided the source of bacteraemia in the case of our patient. Cases of Parvimonas micra bacteraemia and localised infections such as vertebral osteomyelitis are extremely limited; they mostly refer to elderly patients with comorbidities.35 The patient’s history of previous spinal trauma, rendering the vertebral column unstable and more susceptible to the inoculation of infectious agents mainly due to impaired local vascularity, and of rheumatoid arthritis/ immunosuppression, conferred significant predisposition to the development of this condition.36 In patients with rheumatic conditions, especially in the absence of systemic symptomatology, such as fever, other inflammatory conditions of the spine have to be ruled out.37 The positive blood cultures and the detection of abscesses in the surrounding tissues clearly affirmed the infectious aetiology of the clinical condition.

Outcome in the case of anaerobic joint and bone infections depends on the route of pathogen inoculation (postsurgical vs haematogenous spread), time to diagnosis, the presence of implants/ osteosynthesis and the presence of neurological deficits at diagnosis. Besides targeted antibiotic treatment, IV for 2-4 weeks followed by oral treatment usually up to 3 months, a variety of supportive treatment strategies have been used, such as surgical debridement/decompression, and/or hyperbaric oxygen. Outcome is in the vast majority of cases favorable; relapses are associated with the site of infection and the presence of implanted foreign material.38

Table 1. Systematic review of reports of Parvimonas micra spondylodiscitis.
 


CONFLICT OF INTEREST

The authors declare no conflict of interest.

 

ACKNOWLEDGEMENTS

PK, DK contributed to data acquisition, interpretation and manuscript preparation; GS, ES, AV, CZ, KP contributed to data acquisition and interpretation; AP contributed to data interpretation, manuscript preparation, and editing.

 

FUNDING

The authors did not receive any funding relevant to this case report.

References
  1. Herren C, von der Hoeh NH, Zwingenberger S, Sauer D, Jung N, Pieroh P, et al; Spine Section of the German Society for Orthopaedics and Trauma. Spondylodiscitis in Geriatric Patients: What Are the Issues? Global Spine J 2023;13(1_suppl):73S-84S. doi: 10.1177/21925682221121300.
  2. Chen C-T, Wu M-H, Huang T-Y, Li Y-Y, Huang T-J, Lee C-Y, et al. Anaerobic spondylodiscitis: a retrospective analysis. BMC Musculoskelet Disord 2022;23:788. doi: 10.1186/s12891-022-05749-0.
  3. Kim WJ, Park C, Sarraf K. Management of vertebral osteomyelitis in adults. Br J Hosp Med (Lond) 2023;84(1):1-5. doi: 10.12968/hmed.2022.0362.
  4. Conan Y, Laurent E, Belin Y, Lacasse M, Amelot A, Mulleman D, et al. Large increase of vertebral osteomyelitis in France: A 2010-2019 cross-sectional study. Epidemiol Infect 2021;149:e227. doi: 10.1017/S0950268821002181.
  5. Crone CG, Tetens MM, Andersen AB, Obel N, Lebech A-M. Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response Int J Infect Dis 2021 Jul;108:487-93. doi: 10.1016/j.ijid.2021.05.078.
  6. Waheed G, Soliman MAR, Ali AM, Aly MH. Spontaneous spondylodiscitis: review, incidence, management, and clinical outcome in 44 patients. Neurosurg Focus 2019 Jan 1;46(1):E10. doi: 10.3171/2018.10.
  7. Chong BSW, Brereton CJ, Gordon A, Davis JS. Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study. Open Forum Infect Dis 2018;5(3):ofy037. doi: 10.1093/ofid/ofy037.
  8. Pola E, Taccari F, Autore G, Giovannenze F, Pambianco V, Cauda R, et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. European Spine Journal 2018;27(Suppl 2):229-36. doi: 10.1007/s00586-018-5598-9.
  9. Kim DY, Kim UJ, Yu Y, Kim S-E, Kang S-J, Jun K-I, et al. Microbial Etiology of Pyogenic Vertebral Osteomyelitis According to Patient Characteristics Open Forum Infectious Diseases 2020;7(6):ofaa176. doi: 10.1093/ofid/ofaa176. eCollection 2020 Jun.
  10. Chen C-T, Wu M-H, Huang T-Y, Li Y-Y, Huang T-J, Lee C-Y, et al. Anaerobic spondylodiscitis: a retrospective analysis. BMC Musculoskelet Disord 2022;23:788. doi: 10.1186/s12891-022-05749-0.
  11. Pola E, Taccari F, Autore G, Giovannenze F, Pambianco V, Cauda R, et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur Spine J 2018 Jun;27(Suppl 2):229-36. doi: 10.1007/s00586-018-5598-9.
  12. Higashi Y, Nakamura S, Niimi H, Ueno T, Matsumoto K, Kawago K, et al. Spondylodiscitis due to Parvimonas micra diagnosed by the melting temperature mapping method: a case report BMC Infect Dis 2017;17(1):584. doi: 10.1186/s12879-017-2690-4.
  13. Chin TY, Peh WC. Imaging update on musculoskeletal infections. J Clin Orthop Trauma 2021;22:101600. doi: 10.1016/j.jcot.2021.101600.
  14. van Duijvenbode DC, Kuiper JWP, Holewijn RM, Stadhouder A. Parvimonas micra Spondylodiscitis: A Case Report and Systematic Review of the Literature. J Orthop Case Rep 2018;8(5):67-71. doi: 10.13107/jocr.2250-0685.1216.
  15. Durovic A, Eberhard N, Schären S, Widmer AF. Parvimonas micra as a rare cause of spondylodiscitis - case series from a single centre. Swiss Med Wkly 2020;150:w20272. doi: 10.4414/smw.2020.20272.
  16. Yoo LJH, Zulkifli MD, O'Connor M, Waldron R. Parvimonas micra spondylodiscitis with psoas abscess. BMJ Case Rep 2019;12(11):e232040. doi: 10.1136/bcr-2019-232040
  17. Mizuta K, Sonohata M, Nozaki O, Kobatake T, Nakayama D, Morimoto T, et al. Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: a case report BMC Musculoskelet Disord 2018;19(1):336. doi: 10.1186/s12891-018-2255-8
  18. Cleaver LM, Palanivel S, Mack D, Warren S. A case of polymicrobial anaerobic spondylodiscitis due to Parvimonas micra and Fusobacterium nucleatum. JMM Case Rep. 2017;4(4):e005092. doi: 10.1099/jmmcr.0.005092.
  19. Higashi Y, Nakamura S, Niimi H, Ueno T, Matsumoto K, Kawago K, et al. Spondylodiscitis due to Parvimonas micra diagnosed by the melting temperature mapping method: a case report. BMC Infect Dis 2017;17(1):584. doi: 10.1186/s12879-017-2690-4.
  20. Jones SL, Riordan JW, Glasgow AL, Botes J, Boutlis CS. Two cases of spondylodiscitis caused by Parvimonas micra. Intern Med J 2015;45:1090-1. doi: 10.1111/imj.12877.
  21. George IA, Pande A, Parsaei S. Delayed infection with Parvimonas micra following spinal instrumentation. Anaerobe 2015;35:102-4. doi: 10.1016/j.anaerobe.2015.08.004.
  22. Gahier M, Cozic C, Bourdon S, Guimard T, Cormier G. Spinal infections caused by Parvimonas micra. Med Mal Infect 2015;45:397-8. doi: 10.1016/j.medmal.2015.07.006.
  23. Endo S, Nemoto T, Yano H, Kakuta R, Kanamori H, Inomata S, et al. First confirmed case of spondylodiscitis with epidural abscess caused by Parvimonas micra. J Infect Chemother. 2015;21:828-30. doi: 10.1016/j.jiac.2015.06.002.
  24. Medina F, Tatay M, Smati M, Aoun O, Tankovic J, Bouchaud O, et al. Lemierre's syndrome:An unusual presentation. Med Mal Infect 2015;45:328-30. doi: 10.1016/j.medmal.2015.05.009.
  25. Pilmis B, Israel J, Le Monnier A, Mizrahi A. Spondylodiscitis due to anaerobic bacteria about a case of Parvimonas micra infection. Anaerobe 2015;34:156-7. doi: 10.1016/j.anaerobe.2015.05.013.
  26. Dahya V, Chalasani P, Ramgopal M. Peptostreptococcus endocarditis presenting as lumbar discitis in an immunocompromised patient. Am J Med Sci 2015;349:187-8. doi: 10.1097/MAJ.0000000000000377.
  27. González MG, Montes JR, Rosado DG, Reyes SB. Multifocal hematogenous vertebral osteomyelitis due to Parvimonas micra and a subsequent pleural effusion in a diabetic patient. Reumatol Clin 2014;10:191-2. doi: 10.1016/j.reuma.2013.10.002.
  28. Uemura H, Hayakawa K, Shimada K, Tojo M, Nagamatsu M, Miyoshi-Akiyama T, et al. Parvimonas micra as a causative organism of spondylodiscitis: a report of two cases and a literature review. Int J Infect Dis 2014;23:53-5. doi: 10.1016/j.ijid.2014.02.007. Epub 2014 Mar 26.
  29. Fraisse T, Lavigne JP, Lechiche C, Leroux JL, Sotto A. Spondylodiscitis due to Peptostreptococcus spp: a case report. Joint Bone Spine 2009;76:104-5. doi.org/10.1016/j.jbspin.2008.01.029
  30. Brook I. Two cases of diskitis attributable to anaerobic bacteria in children. Pediatrics 2001;107:26. doi: 10.1542/peds.107.2.e26.
  31. Leder KS, Barlam TF. A case of paraspinal abscess and diskitis due to Peptostreptococcus micros. Clin Infect Dis 2000;30:622-3. doi: 10.1086/313735.
  32. Rousseau MC, Harlé JR. Spondylitis caused by Peptostreptococcus. Clin Rheumatol 1998;17(6):538-9. doi: 10.1007/BF01451296
  33. Papasian CJ, McGregor DH, Hodges GR, Kennedy J. Peptostreptococcal vertebral osteomyelitis. J Clin Microbiol 1986;24:633-5. doi: 10.1128/jcm.24.4.633-635.1986.
  34. Shimizu K, Horinishi Y, Sano C, Ohta R. Infection Route of Parvimonas micra: A Case Report and Systematic Review. Healthcare (Basel) 2022;10(9):1727. doi: 10.3390/healthcare10091727.
  35. Watanabe T, Hara Y, Yoshimi Y, Fujita Y, Yokoe M, Noguchi Y. Clinical characteristics of bloodstream infection by Parvimonas micra: retrospective case series and literature review. BMC Infect Dis 2020;20(1):578. doi: 10.1186/s12879-020-05305-y.
  36. Abdelrahman H, Shousha M, Boehm H. Post-traumatic Spondylodiscitis. Update, Series of 17 Patients and Review of the Literature Global Spine J 2016;6(1)Suppl s-0036-1582578-s-0036-158316. doi: 10.1055/s-0036-1582793
  37. Gumà M, Olivé A, Pérez R, Holgado S, Ortiz-Santamaría V, Tena X. Aseptic spondylodiskitis in rheumatic diseases. Clin Exp Rheumatol 2001 Nov-Dec;19(6):740-7.
  38. Walter G, Vernier M, Pinelli PO, Million M, Coulange M, Seng P, et al. Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature. Eur J Clin Microbiol Infect Dis 2014 Aug;33(8):1355-64.